Advances in nanotechnology for the treatment of GBM
Glioblastoma (GBM), a highly malignant glioma of the central nervous system, is the most dread and common brain tumor with a high rate of therapeutic resistance and recurrence. Currently, the clinical treatment methods are surgery, radiotherapy, and chemotherapy. However, owning to the highly invasi...
Main Authors: | Dongyan Wei, Ni Zhang, Shuang Qu, Hao Wang, Jin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2023.1180943/full |
Similar Items
-
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy
by: Jiayi Wen, et al.
Published: (2024-09-01) -
Editorial: Advances in brain tumors diagnosis and treatment
by: Dario de Biase, et al.
Published: (2023-05-01) -
Nanotechnology boosts the efficiency of tumor diagnosis and therapy
by: Ying Yang, et al.
Published: (2023-07-01) -
Recent advances of nanotechnology-based tumor vessel-targeting strategies
by: Dongjie Zhu, et al.
Published: (2021-12-01) -
Trends in Nanotechnology to improve therapeutic efficacy across special structures
by: Muhammad Imran Khan, et al.
Published: (2022-07-01)